Mesoblast Ltd Files December 2024 Update
Ticker: MEOBF · Form: 6-K · Filed: Dec 9, 2024 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Dec 9, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing-update, foreign-private-issuer, sec-compliance
Related Tickers: MESO
TL;DR
MESO filed its Dec 2024 update with the ASX, standard procedure.
AI Summary
Mesoblast Limited announced on December 5, 2024, that it filed a new release with the Australian Securities Exchange. This filing is an update for the month of December 2024, as required by its status as a foreign private issuer.
Why It Matters
This filing serves as an official update from Mesoblast Limited to the SEC and the Australian Securities Exchange, indicating ongoing corporate activities and compliance.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new financial or operational information that would immediately impact the company's risk profile.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- December 5, 2024 (date) — Date of announcement filing
- Australian Securities Exchange (company) — Exchange where announcement was filed
FAQ
What type of filing is this Form 6-K for Mesoblast Limited?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
When did Mesoblast Limited file its announcement with the Australian Securities Exchange?
Mesoblast Limited filed its announcement with the Australian Securities Exchange on December 5, 2024.
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report information that Mesoblast Limited has made or will make public in Australia, as required for a foreign private issuer.
Who is listed as the Chief Executive Officer and Executive Director of Mesoblast Limited?
Silviu Itescu is listed as the Chief Executive Officer and Executive Director of Mesoblast Limited.
Under which act is this filing made?
This filing is made under the Securities Exchange Act of 1934.
Filing Stats: 212 words · 1 min read · ~1 pages · Grade level 17.3 · Accepted 2024-12-09 16:21:23
Filing Documents
- a2024-12x10fdagrantsmesobl.htm (6-K) — 20KB
- exhibit991.htm (EX-99.1) — 13KB
- exhibit991001.jpg (GRAPHIC) — 266KB
- exhibit991002.jpg (GRAPHIC) — 303KB
- exhibit991003.jpg (GRAPHIC) — 204KB
- 0001345099-24-000083.txt ( ) — 1099KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Paul Hughes Paul Hughes Company Secretary Dated December 10, 2024 INDEX TO EXHIBITS Item 99.1 Press release of Mesoblast Ltd, dated December 5, 2024.